about
Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer.Management of hepatic rupture diagnosed after an emergency cesarean sectionLymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvisUterine rupture in a nulliparous woman with septate uterus of the second trimester pregnancy and review in literatureOutcomes of Bleomycin-based electrochemotherapy in patients with repeated loco-regional recurrences of vulvar cancer.Robotic Shaving Technique in 25 Patients Affected by Deep Infiltrating Endometriosis of the Rectovaginal Space.Robotic approach using simple and radical hysterectomy for endometrial cancer with long-term follow-up evaluation.A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cHarmonic scalpel versus conventional electrosurgery in the treatment of vulvar cancer.Postoperative Analgesia after Laparoscopic Ovarian Cyst Resection: Double-blind Multicenter Randomized Control Trial Comparing Intraperitoneal Nebulization and Peritoneal Instillation of Ropivacaine.Laparoscopy with laparotenser in awake patients with subcostal bilateral transversus abdominis plane block and lumbar subarachnoid anesthesia: initial report of three cases. A new frontier in day surgery?Potential benefit of dehydroepiandrosterone supplementation for infertile but not poor responder patients in a IVF program.Conventional fascial technique versus mesh repair for advanced pelvic organ prolapse: Analysis of recurrences in treated and untreated compartments.Robot-assisted laparoscopic transperitoneal deep pelvic lymphadenectomy for metastatic melanoma of the lower limb: initial report of four cases and outcomes at 1-year follow-up.Cost analysis of minimally invasive hysterectomy vs open approach performed by a single surgeon in an Italian center.A rare case of pure uterine giant lipoma.Malignant transformation of vaginal endometriosis treated with neoadjuvant chemotherapy and surgery.Diagnosis and management of a rare case of fetal mediastinal teratoma without non-immunological hydropsTotal laparoscopic radical hysterectomy and pelvic lymphadenectomy in locally advanced stage IB2-IIB cervical cancer patients after neoadjuvant chemotherapyFeasibility and morbidity of total laparoscopic radical hysterectomy with or without pelvic limphadenectomy in obese women with stage I endometrial cancerTotal Laparoscopic Radical Hysterectomy and Pelvic Lymphadenectomy in Early Stage Cervical CancerCaesarean scar pregnancy complicated by placenta percreta followed by suppurative appendicitis after conservative management with methotrexateModified Radical Hysterectomy Versus Extrafascial Hysterectomy in the Treatment of Stage I Endometrial Cancer: Results From the ILIADE Randomized StudyConcurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinomaBrain Metastases from Endometrial CarcinomaSystematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical TrialTotal laparoscopic radical parametrectomy, partial colpectomy, and pelvic lymphadenectomy in patients with occult cervical cancerA dangerous triggerUsefulness of Finasteride to induce ovulation in a non responder hyperandrogenic woman: birth of a healthy male infantAcute spinal cord compression in the third trimester of pregnancyIsobaric laparoscopy using LaparoTenser system in surgical gynecologic oncologyPivotal points in interstitial pregnancy: new insights in conservative medical treatment of non-ruptured interstitial pregnancyCorona mortis exposition during laparoscopic procedure for gynecological malignanciesRobotic transperitoneal ilioinguinal pelvic lymphadenectomy for high-risk melanoma: an update of 18-month follow-up
P50
Q33504341-075A27FE-CB81-4507-A1D1-0D8F790B76F2Q34181445-0172F11B-FF62-435D-BD52-8502CB9291BCQ36320119-C96FF491-A885-4F8C-BD41-772D731B5362Q36611666-0758605F-297C-4C83-8735-D85D11C49F1BQ36705947-762B2F23-70E4-4694-B767-9B8A82A72C11Q39176600-A44B4DB3-B7AC-400F-A402-455DBF3078B5Q39187917-4EB982A6-F6F3-49BD-994C-332CFB9EEDAAQ41442156-891485A5-F85E-4008-B3E6-C2543CE91B1EQ46139364-667D7C58-D517-4039-9760-4ED70D4A3781Q47331949-19B62AA5-4A10-49EA-AB65-23AB65C1E6A9Q47729223-08BC30CD-2177-476B-836B-9A2D0A52A2AFQ47981190-EE7B9E1F-3AE1-43CC-BF9D-18AAA8A10147Q48601641-6E57F860-4CD5-4716-AB16-641534EF38DCQ50855163-08C72F7A-C66A-41C6-A546-5BE6168A7716Q51241749-7E9D7199-3BE2-4318-971F-63777B81DF26Q53053783-C2849E7D-520E-43A8-86E5-C95823EE86E4Q53161106-AEFF4C0E-0C88-46A1-9CB9-7FF47A3D0B89Q53317066-51B4BFEB-DC68-416C-AA59-E6620B7CE548Q56966901-978D5FD4-5611-4CB7-841B-64A9E5B7CA70Q57819091-CA227A06-671F-4030-AE50-D6E0143679A1Q57819109-DD7B45E8-A219-46EA-BD85-14B318D4FB21Q57819131-39B25188-1D42-45F2-A812-74EE4C7A00FBQ57903429-B10BB440-896F-48C9-99F2-E84B05A91935Q57903482-29E1A383-33FC-4757-9695-43125C136E4FQ57903550-E6C5D827-3E7C-4BEA-B440-3CF9C8CF40BDQ57903609-04BE88B5-0092-4529-B4BE-DE1C8BE41BEFQ61900008-D80ABE1A-0CD4-45E0-BCD6-318F1B82BBF6Q84127807-418816A2-AB9B-4452-B71D-ED1A60290996Q84537741-E71BD5AD-35B6-4CD0-9D9C-BEECB568CE26Q84754978-E427901E-836C-4A18-90DB-4A60569517A5Q85734696-C7CBEE4F-5B75-4F53-9F0A-96F8F2A9ABA7Q86671381-C427BFC8-805D-4197-B71F-538CA31A8279Q86986825-D2317ABD-4BD9-4C75-AC78-2F244D0C8BC1Q87036636-0A19FFE7-84FE-4CFC-9EE3-4255A7FC1724Q88348450-D121FD52-76E0-4BA5-88AF-F2AE54FC5D6D
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-8921-7449
@en
name
Antonio Pellegrino
@ast
Antonio Pellegrino
@en
Antonio Pellegrino
@es
Antonio Pellegrino
@nl
type
label
Antonio Pellegrino
@ast
Antonio Pellegrino
@en
Antonio Pellegrino
@es
Antonio Pellegrino
@nl
prefLabel
Antonio Pellegrino
@ast
Antonio Pellegrino
@en
Antonio Pellegrino
@es
Antonio Pellegrino
@nl
P106
P21
P31
P496
0000-0001-8921-7449